Report error Found 41 Enz. Inhib. hit(s) with all data for entry = 11930
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Strom Therapeutics
US Patent
Strom Therapeutics
US Patent
Affinity DataIC50: 6nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Strom Therapeutics
US Patent
Strom Therapeutics
US Patent
Affinity DataIC50: 6nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Strom Therapeutics
US Patent
Strom Therapeutics
US Patent
Affinity DataIC50: 6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Strom Therapeutics
US Patent
Strom Therapeutics
US Patent
Affinity DataIC50: 6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Strom Therapeutics
US Patent
Strom Therapeutics
US Patent
Affinity DataIC50: 6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Strom Therapeutics
US Patent
Strom Therapeutics
US Patent
Affinity DataIC50: 6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Strom Therapeutics
US Patent
Strom Therapeutics
US Patent
Affinity DataIC50: 6.22nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Strom Therapeutics
US Patent
Strom Therapeutics
US Patent
Affinity DataIC50: 8.24nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Strom Therapeutics
US Patent
Strom Therapeutics
US Patent
Affinity DataIC50: 9.11nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Strom Therapeutics
US Patent
Strom Therapeutics
US Patent
Affinity DataIC50: 9.60nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Strom Therapeutics
US Patent
Strom Therapeutics
US Patent
Affinity DataIC50: 12.8nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Strom Therapeutics
US Patent
Strom Therapeutics
US Patent
Affinity DataIC50: 19.7nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Strom Therapeutics
US Patent
Strom Therapeutics
US Patent
Affinity DataIC50: 22.7nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Strom Therapeutics
US Patent
Strom Therapeutics
US Patent
Affinity DataIC50: 23.9nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Strom Therapeutics
US Patent
Strom Therapeutics
US Patent
Affinity DataIC50: 42.6nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Strom Therapeutics
US Patent
Strom Therapeutics
US Patent
Affinity DataIC50: 44.8nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Strom Therapeutics
US Patent
Strom Therapeutics
US Patent
Affinity DataIC50: 46.6nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Strom Therapeutics
US Patent
Strom Therapeutics
US Patent
Affinity DataIC50: 60nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Strom Therapeutics
US Patent
Strom Therapeutics
US Patent
Affinity DataIC50: 63.5nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Strom Therapeutics
US Patent
Strom Therapeutics
US Patent
Affinity DataIC50: 63.7nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Strom Therapeutics
US Patent
Strom Therapeutics
US Patent
Affinity DataIC50: 103nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Strom Therapeutics
US Patent
Strom Therapeutics
US Patent
Affinity DataIC50: 117nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Strom Therapeutics
US Patent
Strom Therapeutics
US Patent
Affinity DataIC50: 123nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Strom Therapeutics
US Patent
Strom Therapeutics
US Patent
Affinity DataIC50: 150nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Strom Therapeutics
US Patent
Strom Therapeutics
US Patent
Affinity DataIC50: 196nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Strom Therapeutics
US Patent
Strom Therapeutics
US Patent
Affinity DataIC50: 231nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Strom Therapeutics
US Patent
Strom Therapeutics
US Patent
Affinity DataIC50: 317nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Strom Therapeutics
US Patent
Strom Therapeutics
US Patent
Affinity DataIC50: 351nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Strom Therapeutics
US Patent
Strom Therapeutics
US Patent
Affinity DataIC50: 351nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Strom Therapeutics
US Patent
Strom Therapeutics
US Patent
Affinity DataIC50: 413nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Strom Therapeutics
US Patent
Strom Therapeutics
US Patent
Affinity DataIC50: 453nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Strom Therapeutics
US Patent
Strom Therapeutics
US Patent
Affinity DataIC50: 460nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Strom Therapeutics
US Patent
Strom Therapeutics
US Patent
Affinity DataIC50: 505nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Strom Therapeutics
US Patent
Strom Therapeutics
US Patent
Affinity DataIC50: 522nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Strom Therapeutics
US Patent
Strom Therapeutics
US Patent
Affinity DataIC50: 568nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Strom Therapeutics
US Patent
Strom Therapeutics
US Patent
Affinity DataIC50: 1.09E+3nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Strom Therapeutics
US Patent
Strom Therapeutics
US Patent
Affinity DataIC50: 1.31E+3nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Strom Therapeutics
US Patent
Strom Therapeutics
US Patent
Affinity DataIC50: 2.64E+3nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Strom Therapeutics
US Patent
Strom Therapeutics
US Patent
Affinity DataIC50: 2.93E+3nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Strom Therapeutics
US Patent
Strom Therapeutics
US Patent
Affinity DataIC50: 3.01E+3nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Strom Therapeutics
US Patent
Strom Therapeutics
US Patent
Affinity DataIC50: 7.93E+3nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair







































